Patent ID: 9439900
Filing Date: 2016-09-13
CPC Classification: A61K,A61P

Claim Text:
1. A pharmaceutical composition in the form of a tablet suitable for sublingual administration comprising: buprenorphine, or a pharmaceutically acceptable salt thereof, provided in the form of microparticles, a weak acid, provided in the form of particles, which particles are separate from the microparticles of buprenorphine, or a pharmaceutically acceptable salt thereof, a disintegrant, and naloxone or a pharmaceutically acceptable salt thereof, wherein the per tablet dosage of buprenorphine (calculated as the free base) is 11.4 mg, 8.6 mg, 5.7 mg, 2.9 mg, or 1.4 mg; and wherein the per tablet dosage ratio of buprenorphine:naloxone dose (calculated as free bases) is about 4:1.